CNA Financial’s MaxCyte MXCT Stock Holding History

CNA Financial’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-47,974	Closed	-$335K	–	186
2022 Q1	$335K	Sell	47,974 -11,929	-20%	-$81.4K	0.1%	169
2021 Q4	$610K	Buy	59,903 +36,840	+160%	+$396K	0.16%	143
2021 Q3	$282K	Buy	+23,063	New	+$348K	0.08%	190

Other funds holding MXCT

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RGI

River Global Investors London, United Kingdom $515M AUM 24.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CNA Financial's MXCT Position: Q2 2022 in Review

CNA Financial sold out of MaxCyte (MXCT) in Q2 2022, closing a stake of 47,974 shares — an estimated $335K sold.

CNA Financial first reported a position in MXCT in Q3 2021 and held it in 3 quarters. The position peaked at $610K in Q4 2021. 102 funds tracked by Wall St. Rank hold MXCT as of Q2 2022.

CNA Financial reported no remaining MaxCyte position as of Q2 2022 after selling out during the quarter.
CNA Financial sold 47,974 MaxCyte shares in Q2 2022, an estimated $335K.
CNA Financial first reported a position in MaxCyte in Q3 2021 and held it in 3 quarters.
CNA Financial's MaxCyte position peaked at $610K in Q4 2021.
102 funds tracked by Wall St. Rank held MaxCyte as of Q2 2022.

Based on CNA Financial's 13F filing for Q2 2022, filed 9 Aug 2022.